Is NBIX a good stock to buy? We came across a bullish thesis on Neurocrine Biosciences, Inc. on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on NBIX. Neurocrine Biosciences, Inc.'s share was trading at $159.76 as of June 12th. NBIX’s trailing and forward P/E were 24.58 and 22.57 respectively according to Yahoo Finance.
[caption id="attachment_575381" align="aligncenter" width="750"]Neurocrine Biosciences, Inc. (NBIX) is a San Diego-based biopharmaceutical company focused on central nervous system,...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.